On Friday, August 22nd, the U. S. Drug Enforcement Administration (DEA) published a Final Rule moving hydrocodone combination products (HCPs) from Schedule III to the more-restrictive Schedule II. This Final Rule imposes the regulatory controls and sanctions applicable to Schedule II substances on those who handle or propose to handle HCPs. The rule goes into effect 45 days from its publish date.
More Latest News
September 12, 2017
Consideration of the Texas model medication coverage for evacuees in shelters is under consideration in Florida Continue reading
September 8, 2017
Find out how to volunteer and know the restrictions regarding advanced supplies of Schedule II controlled substances. Continue reading